Navigation Links
Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
Date:8/15/2013

and response rate. Human data to date have shown a favorable safety profile. Inovio's lead vaccine, a therapeutic against HPV-caused pre-cancers and cancers, is in phase II. Other phase I and preclinical programs target prostate, breast, and lung cancers as well as HIV, influenza, malaria and hepatitis C virus. Partners and collaborators include the University of Pennsylvania, Merck, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, University of Southampton, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove sa
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results
2. Inovio Pharmaceuticals Responds to Market Activity
3. Inovio Pharmaceuticals Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence
4. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
5. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
6. Inovio Pharmaceuticals to Present at OneMedForumNY 2013 Investor Conference
7. Inovios Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
8. Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
9. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
10. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
11. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
(Date:8/29/2014)...  In part four of a blog ... as a strategic asset, Mary Baxter, MBA, RPh ... Health,s Innovation Delivery Solutions business, discusses how expanding patient ... and patients. "Every hospital pharmacist knows that ... job in a value-based healthcare world," Baxter says. "For ...
(Date:8/29/2014)... -- Pixcelldata, the innovative Irish developer of ... major new deal with Dutch based eX-Path, global providers ... Marius Nap . The announcement was ... Pathology which is taking placing between August 30th and ... where Pixcelldata will demonstrate its innovative solution. ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... , LONDON and PHILADELPHIA, Dec. 11 ... form of breast cancer experienced a median survival of 14 ... plus HERCEPTIN® (trastuzumab). The results of the Phase III study ... Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San ...
... , , BATESVILLE, Ind., ... introduction of Hill-Rom,s Advanta(TM) 2 Bed for use in medical-surgical areas of ... with key safety features and the flexibility to use a variety of ... new solution to our customers. It combines the best features of Hill-Rom,s ...
Cached Medicine Technology:GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4
(Date:8/29/2014)... 2014 Floors of hospitals and other ... socks. Also, many patients are relegated to lying down ... recovery, Alzheimer’s, etc. Two inventors from Perrysburg, Ohio, have ... safety. , This special pair of socks helps prevent ... patients who are relegated to beds or chairs from ...
(Date:8/29/2014)... Francisco, CA (PRWEB) August 30, 2014 ... 10 best web conference providers in the online service ... the list were global leaders Webex, GotoMeeting and Infinite. ... the industry users have to determine which provider is ... Essentially, web conference businesses search for compelling consumer goods ...
(Date:8/29/2014)... by volunteering are getting more out of it than ... health boost! , A new study, led ... and published online this week in Psychological Bulletin ... at all the available peer-reviewed evidence regarding the psychosocial ... Lead investigator Dr. Nicole Anderson, together with scientists from ...
(Date:8/29/2014)... 29, 2014 University of Western States ... professionals, announced that Daniel Redwood, DC, director of the ... of the Year,” by the Missouri State Chiropractors Association ... 21. , Patrick Montgomery, DC, president of the MSCA, ... the Missouri House Task Force for Medicaid Reform, in ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Evolutions Medical ... Barbara in the Santa Barbara News-Press Readers’ Choice 2014 ... the Readers’ Choice poll as Best Medical Spa. The ... reads the following about Evolutions Medical Spa recognition: , ... it is recognized as a top-notch, cutting-edge medical spa ...
Breaking Medicine News(10 mins):Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3
... who received testosterone supplementation increased lean body mass and decreased ... in mobility or cognition compared with men who did not ... 2 issue of JAMA. , Male aging is associated ... testosterone, occurring to a greater extent in some men than ...
... prevalent than thought. However, when they do exist, nightmares ... as early as five months, according to a study published ... The study, led by Valrie Simard, under the direction of ... children in the Province of Quebec, who were assessed by ...
... A study published in the January 1 issue of ... taken three to seven nights per week for up ... sleep onset and maintenance, and also improved next-day concentration ... study focused on 1,018 patients between 18 and 64 ...
... tonsillitis substantially improve a patients quality of live in ... published as a supplement to the January 2008 issue ... involving 72 adults, patients showed improvement in all six ... (TAHSI), a scale used to measure the quality of ...
... that treat depression, schizophrenia and other psychotic conditions and ... not be triggering the most appropriate response in those ... The Ohio State University Medical Center examined the serotonin ... the neurotransmitter serotonin. , This study examined the early ...
... seek out support from friends, experts advise , , MONDAY, Dec. ... 50 will resolve to start a new fitness program. , ... for helping to keep that resolve: , Get a ... exercise program and to find out if you need to ...
Cached Medicine News:Health News:Testosterone supplementation for older men appears to have limited benefit 2Health News:Preschoolers' nightmares less prevalent, are trait-like and associated with personality 2Health News:Preschoolers' nightmares less prevalent, are trait-like and associated with personality 3Health News:Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia 2Health News:Some antipsychotic drugs may be missing their mark 2Health News:Make That New Year's Fitness Resolution Stick 2
... 25,000 units Penicillin/25,000 ... Cell Culture Reagent and ... in accordance with cGMP ... culture tested to assure ...
Penicillin-Streptomycin-Glutamine (100X) liquid...
Penicillin-Streptomycin liquid...
... combination of penicillin and streptomycin which ... and gram negative bacteria when used ... I.U. Penicillin/100,000 g/mL Streptomycin per liter. ... water at concentrations of 5,000 I.U. ...
Medicine Products: